Analyst Activity - Numis Securities Ltd Reiterates Hold on IMI plc (LON:IMI)
- Author: Darren Santiago Feb 28, 2017,
Feb 28, 2017, 0:48
Five research analysts have rated the stock with a sell rating, five have assigned a hold rating and three have issued a buy rating to the stock. Royal Bank Of Canada reissued a "sector perform" rating and set a GBX 2,450 ($30.11) price objective on shares of Rotork p.l.c.in a report on Wednesday, October 28th. Serco Group plc has a 52 week low of GBX 85.20 and a 52 week high of GBX 151.10. Goodbody restated a buy rating on shares of Draper Esprit PLC in a research report on Tuesday, November 1st. The company presently has a consensus rating of "Hold" and an average price target of GBX 194.31 ($2.39). Stockholders of record on Thursday, February 9th will be paid a GBX 3.80 ($0.05) dividend. The business's 50 day moving average is 659.43 and its 200 day moving average is 649.73. This represents a dividend yield of 1.08%.
Following an update released by analysts at JP Morgan Cazenove on Friday the broker has now set a "Neutral" rating on shares of RSA Insurance Group PLC (LON:RSA) with a price target of 585.
The number of shares UDG Healthcare PLC now has in issue is 246,764,000, which have a value of 670.75 per share calculating UDG Healthcare PLC's market capitalisation to 1.66B GBP. This is a boost from Ascential PLC's previous dividend of $1.50. If you are viewing this story on another publication, it was illegally copied and reposted in violation of U.S. and global trademark and copyright legislation.
MMA fighter makes advances to Ronda Rousey after bludgeoning her BF
While one might feel for Rousey at this moment, this could also see her going for a full war cry against Lewis, a heavyweight fighter.
In other news, insider Tim O'Toole purchased 6,509 shares of the stock in a transaction on Friday, February 24th.
Draper Esprit plc, formerly Ingleby (1994 plc), is a United Kingdom-based company, which focuses to raise capital through a listing on Alternative Investment Market (AIM) in order to pursue a direct purchase of a regulated venture capital management business and an associated portfolio of investments. The Ashfield Commercial & Medical Services segment is engaged in the provision of sales, marketing and healthcare communications services to pharmaceutical companies, and it also provides sales teams, healthcare communications, telesales, nurse educators, medical information, pharmacovigilance, regulatory and event management services to over 300 healthcare companies in approximately 20 countries. The Company operates through four segments: Controls, Fluid Systems, Gears and Instruments.